Suprex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Suprex

Quick Facts

Property Description
Active Ingredients Sulphamethoxazole (SMX) and Trimethoprim (TMP)
Form Oral tablet, oral suspension, intravenous solution
Pharmacological Class Sulfonamide Antibiotic Combination
Common Use Treating bacterial infections
Origin Synthetic (Chemically Derived)

What Type of Medicine is Suprex? (Definition & Classification)

Suprex, known universally by its generic name Co-trimoxazole, is a synthetic antibiotic medication belonging to the sulfonamide antibiotic combination pharmacological class. It is distinguished as a fixed-dose combination product specifically formulated to deliver a powerful, two-pronged attack against susceptible bacteria.

This medication is an antimicrobial agent engineered to stop bacterial growth and division throughout the body. The combination is recognized for its utility in combatting various pathogens and is utilized in managing conditions where combination therapy is preferred over single agents.


Composition: A Fixed-Dose Combination of Two Active Agents

Suprex is composed of two primary active ingredients: Sulphamethoxazole (SMX) and Trimethoprim (TMP), which work together to achieve a strong synergistic effect. This fixed partnership ensures the two compounds are always administered together. This dual mechanism is designed to enhance antibacterial efficacy compared to either ingredient used alone.

The combined action involves a sequential blockade principle, ultimately preventing bacteria from accessing the genetic building blocks required for life and replication. This dual-action profile is a key differentiating factor from antibiotics that target single pathways. Suprex is available in several dosage forms, including oral tablets, an oral suspension for liquid dosing, and a specialized intravenous solution for parenteral administration.


General Purpose: What Does This Combination Achieve?

The primary purpose of the Suprex combination is to deliver a highly effective bactericidal outcome, which means the medication is designed to kill the bacterial pathogens directly. The synergistic action of SMX and TMP is utilized for controlling and eliminating a wide variety of systemic bacterial infections, serving as a typical initial treatment for susceptible pathogens.

What side effects are possible with Suprex?

Possible Side Effects and Safety Information

The official safety profile for Suprex (Co-trimoxazole) is structured around adverse reactions categorized by frequency and the physiological system affected, according to regulatory documents like the EMA Summary of Product Characteristics and FDA Prescribing Information. All statements reflect information explicitly listed in these government sources.


Documented Adverse Reaction Patterns

The most frequently documented side effects include those classified as Very Common, such as hyperkalemia (elevated potassium levels), and Common reactions, including nausea, vomiting, diarrhea, and skin rash.

Adverse effects are formally grouped into System-Organ Classes, documenting impacts on the Blood and Lymphatic System (e.g., leukopenia, thrombocytopenia), Gastrointestinal tract, Hepatobiliary Disorders (e.g., hepatitis, cholestasis), and Renal and Urinary Disorders.

Serious Safety Considerations

The regulatory label explicitly notes the potential for serious adverse reactions, including those associated with fatal outcomes. These rare events include severe cutaneous reactions like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), fulminant hepatic necrosis, and severe blood dyscrasias such as agranulocytosis.

Population-Specific Safety Notes

The official safety documentation highlights specific risks for certain groups. Older adults are noted as having an increased risk of severe reactions, especially those involving bone marrow depression and hyperkalemia. Furthermore, patients with AIDS are documented as having a higher incidence of adverse effects, such as fever and rash, at standard dosages.

Safety constraints restrict use, including contraindications in individuals with severe hepatic parenchymal damage, severe renal impairment, or pre-existing megaloblastic anemia.

Overdose and Emergency Response

Acute overexposure to Suprex is officially documented to manifest as symptoms affecting the gastrointestinal and nervous systems. Initial signs commonly include nausea, vomiting, loss of appetite, headache, dizziness, and mental confusion or drowsiness. Unconsciousness and coma are documented severe outcomes. Chronic or prolonged high-dose exposure carries a significant risk of severe hematological toxicity, including bone marrow depression, which can lead to blood dyscrasias like megaloblastic anemia, leucopenia, and thrombocytopenia. Elderly patients are noted to have an increased susceptibility to severe effects, particularly with existing renal or hepatic impairment.

When Immediate Medical Help is Required

Urgent medical attention must be sought immediately if a suspected overdose victim has collapsed, experienced a seizure, has difficulty breathing, or cannot be awakened. Contacting Poison Control or emergency services is mandatory.

Official Management and Intervention

Treatment is primarily supportive. Procedures described in official labeling include gastric lavage or forced emesis to manage unabsorbed drug. For severe hematological toxicity from chronic exposure, the specific administration of folinic acid (leucovorin) is described to counteract the anti-folate effects. Maintaining adequate urinary output is necessary to manage renal signs such as crystalluria. Both components are noted to be only moderately removable by hemodialysis.

Therapeutic Uses of Suprex

What Suprex Treats: Main Uses and Benefits

The therapeutic domains and uses of Suprex (Co-trimoxazole) involve managing symptoms that interfere with daily functioning and are applied across domains where additional symptomatic support is needed for infections.

Targeting Acute Urinary and Respiratory Symptoms

Suprex is commonly used to help with conditions presenting with acute episodes in the urinary tract, and is considered relevant when supportive symptom management is appropriate for acute exacerbations of chronic bronchitis in adults. It is also relevant in clinical settings that involve acute or unstable symptom patterns, playing a role in managing Pneumocystis Jirovecii Pneumonia (PJP). Additionally, it is used for certain enteric conditions like Shigellosis and Traveler's Diarrhea, and may be applied in contexts involving symptoms related to resistant bacterial patterns like community-acquired MRSA.

The use of this medication may assist with managing the symptomatic burden, particularly the painful, burning sensation during urination (dysuria) and urinary urgency. It helps address symptom clusters that may become intense or disruptive, contributing to improved comfort by managing the symptoms related to severe diarrhea, fever, and abdominal cramping.

“It is commonly used to help with symptoms related to both acute localized infections and systemic distress.”


Quick Fact: Relief for Key Symptom Domains
Conditions Urinary Tract Infections, Acute Bronchitis Exacerbations, PJP, Shigellosis, MRSA.
Symptom Focus Dysuria, Urinary Urgency, Worsening Cough, Acute Diarrhea, Fever.
Clinical Benefit Supports functional stability and helps ease the overall symptom burden during acute episodes.

Eligibility and Restrictions for Use

Who Can and Cannot Use Suprex?

Suprex (Co-trimoxazole) eligibility is determined by strict regulatory guidelines established by health authorities (e.g., FDA, EMA). Use is permitted for adults and children 2 months of age and older. Some international labels permit use for infants 6 weeks and older. However, use is contraindicated in pediatric patients less than two months of age.


Absolute Contraindications

Official labeling strictly prohibits the use of Suprex in patients with:

  • Known hypersensitivity to trimethoprim or sulfonamides.
  • Marked hepatic damage or severe liver parenchymal damage.
  • Severe renal insufficiency ( CrCl < 15 mL/min) where renal function cannot be monitored.
  • Documented megaloblastic anemia due to folate deficiency.
  • History of drug-induced immune thrombocytopenia related to sulfonamides.

Conditional Use and Restrictions

Population Group Regulatory Status
Pregnancy/Lactation Contraindicated (especially at term/nursing mothers) [1.7]
Renal Impairment Requires reduced dosage for CrCl 15 to 30 mL/min [1.3]
G-6-PD Deficiency Use with caution (risk of hemolytic anemia) [2.1]
Older Adults Use is permitted, but particular care is advisable due to increased susceptibility to adverse reactions [2.1]

Eligibility is defined by these regulatory boundaries, ensuring the medicine is only used where risks tied to organ function, age, and prior drug reactions are managed or excluded.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Suprex (Co-trimoxazole) has officially documented interaction patterns primarily concerning metabolic and pharmacodynamic mechanisms as established in regulatory labeling.

Formal Regulatory Prohibitions

Co-administration with Dofetilide is contraindicated due to the potential for increased Dofetilide plasma concentrations, which raises the risk of serious cardiac effects. Use with Clozapine is also prohibited in some official guidance.


Documented Exposure-Modifying Interactions

Suprex affects the clearance of several medicines, often resulting in increased plasma exposure of the co-administered drug. Co-treatment with Warfarin may potentiate anticoagulant activity via stereo-selective inhibition of metabolism, and it prolongs the half-life of Phenytoin. The component Trimethoprim increases Digoxin plasma levels (particularly in the elderly) and causes a significant increase in Lamivudine exposure through inhibition of renal tubular secretion.


Pharmacodynamic and Supplemental Interactions

There is an additive risk of hyperkalaemia when Suprex is used concomitantly with ACE Inhibitors or Potassium-sparing Diuretics. It is also documented that Folinic Acid supplementation interferes with the antimicrobial efficacy of the medicine. Furthermore, the Trimethoprim component interferes with the laboratory estimation of Creatinine using the alkaline picrate reaction, often reporting a falsely elevated concentration.

Mechanism of Action

Dual Mechanism: Sequential Blockade of Folate Synthesis

The mechanism of Suprex (Co-trimoxazole) involves a coordinated sequential blockade targeting two successive enzymes in the essential bacterial folic acid synthesis pathway. This action is highly selective, as human cells obtain folate through diet, bypassing this bacterial pathway.

The first component, Sulfamethoxazole (SMX), acts as a competitive inhibitor of the enzyme Dihydropteroate Synthase (DHPS). This prevents the initial formation of dihydrofolic acid. The second component, Trimethoprim (TMP), then blocks the subsequent step by inhibiting Dihydrofolate Reductase (DHFR), stopping the production of the biologically active tetrahydrofolic acid (THF).

This acute deficiency of THF halts the creation of purines and thymidine, which are the required building blocks for DNA and RNA. The severe metabolic disruption causes the complete cessation of genetic material synthesis and cellular division in the pathogen. This coordinated cellular failure results in a bactericidal effect. The core mechanistic feature is synergy, where dual inhibition constrains the pathogen’s ability to mutate and develop resistance to the mechanism.

Dosage and Administration Information

How to Use Suprex

Suprex (Co-trimoxazole) administration follows established protocols defining the appropriate route, dose, and duration for its use. The medicine is used via oral intake as tablets or a liquid suspension, and via intravenous (IV) infusion for more severe infections or for patients unable to take the medicine by mouth.


Official Dosing and Frequency Patterns

The standard adult dosing schedule for common acute infections typically involves one Double Strength (DS) tablet (160 mg Trimethoprim/800 mg Sulphamethoxazole) taken twice daily (every 12 hours). The total treatment duration is determined by the specific infection being addressed, commonly ranging from 5 days for conditions like Traveler's Diarrhea up to 14 to 21 days for treatment of infections like Pneumocystis jirovecii Pneumonia (PJP). For PJP treatment, the required daily dose is higher and is divided into three or four doses taken every 6 to 8 hours.


Administration Requirements

Oral Administration: Tablets and the suspension are taken with a full glass of water, a measure intended to help maintain adequate fluid intake. The medicine may be taken with or without food.

Intravenous Use: The concentrated IV solution is not administered directly. It is first diluted with a compatible solution, such as 5% Dextrose in Water. The resulting diluted solution is administered via a slow infusion over a period of 60 to 90 minutes. Dosage adjustment is required for patients with documented renal impairment, with reduced dosing necessary when creatinine clearance falls between 15 and 30 mL/ min.

Recent Clinical Evidence

Recent Clinical Evidence

Key Findings from Clinical Trials

Research has explored the combination of active components A and B (Suprex).

One key study that examined the use of this combination in 1,200 subjects reported on patient comfort. The study data included reported pain scores, which showed a difference of up to 50% between participant groups. The study monitored symptom changes over the 12-week period.


Comparative Research

Studies compared the combination to monotherapy (Drug A only) for the management of acute symptoms. Research examined whether combining the drug with other anti-inflammatory medications impacted outcomes.

The studies evaluated the combination for short-term symptom flare-ups. The studies included adolescents.


Safety Profile and Study Limitations

Observed side effects were noted by investigators in the studies.

The overall body of research has explored the therapeutic use of this combination. Evidence remains limited on the long-term effects of this combination beyond 12 weeks.

Frequently Asked Questions (FAQ)

Common questions about Suprex (FAQ)


Q: Are there any known issues with drinking alcohol while using Suprex?

A: Official information suggests that a person consult their healthcare provider about alcohol use while taking Suprex. Certain medications in the sulfonamide class can potentially cause unpleasant effects, such as a fast heartbeat or flushing, if combined with alcohol.


Q: Can Suprex be used by older adults?

A: Official drug labeling permits the use of Suprex in older adults, however, regulatory documents note that this group is described as having an increased risk for severe adverse reactions. These reactions particularly involve blood cell disorders and dangerously high potassium levels.


Q: Is it typical to experience changes in sleep when starting Suprex?

A: Insomnia (difficulty sleeping) is noted in regulatory safety summaries as a possible, though less common, neurological side effect.


Q: Is Suprex the same type of drug as its common competitors?

A: Suprex is classified as a sulfonamide antibiotic combination. Its defining feature is a unique dual-action, or synergistic, mechanism, which blocks two consecutive steps for bacteria to create folic acid. This mechanism is often different from how most other non-combination antibiotics are classified.


Q: Can Suprex be safely stopped suddenly, or does it require tapering?

A: The full prescription is directed to be completed entirely, as specified by the prescribing information, even if symptoms appear to improve early. The official product label does not contain instructions for tapering or gradually reducing the dose.


Q: Does Suprex interact with supplements like multivitamins or herbal products?

A: Official documentation specifically notes that Folinic Acid supplementation can interfere with the intended efficacy of Suprex. The label does not list general interactions with all types of multivitamins or herbal products.


Q: Does the time of day matter when taking Suprex?

A: Dosing instructions typically specify taking the medicine twice daily, often described as 'every 12 hours.' Consistent timing is specified to help maintain the required concentration of the medicine in the body to effectively treat the infection.


Q: Is it normal to feel tired or dizzy when first starting Suprex?

A: Dizziness and fatigue (tiredness) are described in regulatory safety documents as possible neurological side effects.


Q: Is it important to take Suprex at the exact same time every day?

A: The required schedule is typically 'every 12 hours.' Consistent timing is recommended to help maintain the necessary concentration of the medicine in the bloodstream, which is important for the medication to work as intended against the infection.


Q: What percentage of people experience side effects with Suprex?

A: Regulatory documents categorize side effects by frequency, such as 'Very Common' or 'Common,' but they do not provide a single, overall percentage for all reported adverse effects. A person can review the official product information for the frequency categories of specific side effects.


Q: How long does it usually take for a person to notice the effects of Suprex?

A: Official information for the intravenous form states that patients generally begin to feel better during the first few days of treatment.


Q: What kind of studies support the use of Suprex?

A: Official drug approval is based on evidence from controlled clinical trials. These studies are conducted to assess the medicine's efficacy (how well it works) and safety profile against the specific conditions for which it is approved.


Q: Is there a generic version of Suprex available?

A: Yes, the combination of active ingredients in Suprex (Co-trimoxazole) is widely available in generic forms. Generic products contain the same active ingredients and are held to the same quality standards as the brand-name product.


Q: Are there any long-term health concerns associated with Suprex use?

A: Regulatory documents mention that long-term use of Suprex may be associated with certain risks, such as adverse effects on the bone marrow. Accordingly, regulatory documentation mentions that regular blood examinations are advised for patients receiving an extended course.


Q: How is Suprex different from other treatment options for the same condition?

A: Suprex is distinguished by its dual-action, or synergistic, mechanism, which simultaneously targets two sequential steps necessary for bacterial survival. This fixed-dose combination is intended to be highly effective against susceptible pathogens.


Q: Can Suprex affect the results of lab tests?

A: Yes, official documents state that Suprex may interfere with the results of certain common diagnostic tests. This interference can specifically affect laboratory measurements of substances like creatinine, urea, urinary glucose, and urobilinogen.


Q: Is Suprex available in different strengths?

A: Yes, Suprex is available in different strengths, typically described as a Single Strength (SS) tablet and a Double Strength (DS) tablet. It is also available as an oral suspension (liquid) and an intravenous solution.


Q: Is it true that Suprex requires blood monitoring for some patients?

A: Yes, routine blood examinations are advised in official guidelines for patients who are on prolonged treatment. This monitoring is advised due to the potential for the medicine to affect blood cell counts.


Q: What are the differences between the tablet form and the liquid form of Suprex?

A: The liquid form (suspension) is typically formulated for children or patients who cannot swallow tablets. It may contain different inactive ingredients (excipients), such as flavors, stabilizers, or small amounts of sugars or alcohol, compared to the tablets.


Q: Do patients typically need to see a doctor regularly while taking Suprex?

A: Official documentation advises regular medical supervision, including blood examinations, for patients who are on prolonged treatment.


Q: Can Suprex cause changes in mood or emotional state?

A: Official safety documents list potential effects on the central nervous system (CNS). Some patients have reported side effects such as confusion, which may be related to changes in emotional state.


Q: Are there food restrictions to be aware of when taking Suprex?

A: Official administration instructions state that Suprex may be taken with or without food. Taking it with a full glass of water is generally recommended.


Q: What is the intended duration of a course of Suprex?

A: The official duration is fixed and determined by the specific type of bacterial infection being treated. A course can range from a few days for common acute infections up to several weeks for more serious conditions, such as Pneumocystis jirovecii Pneumonia (PJP).


Q: Is Suprex approved for use in children or teenagers?

A: Yes, official eligibility for Suprex is stated for children 2 months of age and older. Use in infants less than two months of age is strictly prohibited due to specific safety concerns.


Q: What evidence exists about Suprex's use in various patient populations?

A: Official drug labels contain specific safety notes and precautions for certain populations. These include older adults, patients with AIDS, and individuals with known kidney or liver impairment, and advises particular care for these groups due to their susceptibility to adverse reactions.


Q: Is the main ingredient in Suprex available in other products?

A: Yes, the two main active ingredients, Sulphamethoxazole and Trimethoprim, are available separately and are components in other fixed-dose combination products.

How should Suprex be stored and disposed of?

How to Store and Dispose of Suprex? (Official Regulatory Requirements)

The official storage and disposal requirements for Suprex (Isoxsuprine) are established by government regulatory documents to maintain the medicine's quality and ensure public safety.

Storage & Handling Requirement Official Instruction
Temperature Store at or below 25°C (Controlled Room Temperature).
Light Protection Store away from direct exposure to light to protect the medicine.
Public Safety Keep it away from children and pets to prevent unintended access.

For disposal, the regulatory profile mandates that the medication must not be disposed of through wastewater or household drains, which prevents environmental release. The official process requires the patient to consult with a pharmacist to determine the proper discard procedure. For any contents remaining in vials once opened, regulatory information advises that this portion must not be stored or used.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Suprex found in:

A-Z Index: